Company intelligence / Profile preview
Pareto Bio
California, United Statesparetobio.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Pareto Bio is a seed-stage biopharma company developing novel microbiome-based interventions aimed at retraining the immune system to tolerate allergens and potentially cure atopic diseases, with initial focus on food allergy. As of 2025, no clinical results or clinical trials are publicly disclosed[2][3].
- Therapeutic areas
- Immunology
- Modalities
- Microbial therapyLive biotherapeutic product therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Pareto Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pareto Bio.